Response to Local Inflammation of IL-1β-Converting Enzyme-Deficient Mice

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1818-1824

  Fantuzzi, Giamila ^a,e   Ku, George ^b   Harding, Matthew W ^b   Livingston, David J ^b   Sipe, Jean D ^c   Kuida, Keisuke ^d,f   Flavell, Richard A ^d   Dinarello, Charles A ^a,e,g  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VERTEX PHARMACEUTICALS   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CYSTEINE PROTEINASE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1BETA CONVERTING ENZYME; SERUM AMYLOID A; TURPENTINE; ZYMOSAN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BODY WEIGHT; CELL MOTION; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INFLAMMATION; MOUSE; MOUSE MUTANT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; APOLIPOPROTEINS; BODY WEIGHT; CASPASE 1; CELL MOVEMENT; CYSTEINE ENDOPEPTIDASES; CYTOKINES; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-1; MICE; MICE, MUTANT STRAINS; SERUM AMYLOID A PROTEIN; TURPENTINE; ZYMOSAN;

EID: 0031568401     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dinarello, C. A. 1996. Biological basis for interleukin-1 in disease. Blood 87: 2095.
2. Jobling, S. A., P. E. Auron, G. Gurka, A. C. Webb, B. McDonald, L. J. Rosenwasser, and L. Gehrke. 1988. Biological activity and receptor binding of human prointerleukin-1β and subpeptides. J. Biol. Chem. 263:16372.
3. Matsushima, K., M. Taguchi, E. J. Kovacs, H. A. Young, and J. J. Oppenheim. 1986. Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. J. Immunol. 136:2883.
4. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, K. O. Elliston, J. M. Ayala, F. J. Casano, J. Chin, G. J.-F. Ding, L. A. Egger, E. P. Gaffney, G. Limjuco, O. C. Palyha, S. M. Raju, A. M. Rolando, J. P. Salley, T.-T. Yamin, T. D. Lee, J. E. Shively, M. MacCross, R. A. Mumford, J. A. Schmidt, and M. Tocci. 1992. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768.
5. Howard, A. D., M. J. Kostura, N. Thornberry, G. J. F. Ding, G. Limjuco, J. Weidner, J. P. Salley, K. A. Hogquist, D. D. Chaplin, R. A. Mumford, J. A. Schmidt, and M. J. Tocci. 1991. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1α. J. Immunol. 147:2964.
6. Young, P. R., D. J. Hazuda, and P. L. Simon. 1988. Human interleukin 1β is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA. J. Cell Biol. 107:447.
7. Cerretti, D. P., C. J. Kozlosky, B. Mosley, N. Nelson, K. Van Ness, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner, and R. A. Black. 1992. Molecular cloning of the interleukin-1β converting enzyme. Science 156:97.
8. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S.-S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000.
9. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld, E. Towne, D. Tracey, S. Warwell, F.-Y. Wei, W. Wong, R. Kamen, and T. Seshadri. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401.
10. Black, R. A., S. R. Kronheim, M. Cantrell, M. C. Deeley, C. J. March, K. S. Prickett, J. Wignall, P. J. Conlon, D. Cosman, T. P. Hopp, and D. Y. Mochizuki. 1988. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 263:9437.
11. Kapur, V., M. W. Majesky, L.-L. Li, R. A. Black, and J. M. Musser. 1993. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 90:7676.
12. Dinarello, C. A., J. G. Cannon, J. W. Mier, H. A. Bernheim, G. LoPreste, D. L. Lynn, R. N. Love, A. C. Webb, P. E. Auron, R. C. Reuben, A. Rich, S. M. Wolff, and S. D. Putney. 1986. Multiple biological activities of human recombinant interleukin 1. J. Clin. Invest. 77:1734.
13. Hazuda, D. J., J. Strickler, F. Kueppers, P. L. Simon, and P. R. Young. 1990. Processing of precursor interleukin-1 beta and inflammatory disease. J. Biol. Chem. 266:6318.
14. Irmler, M., S. Hertig, H. R. MacDonald, R. Sadoul, J. D. Becherer, A. Proudfoot, R. Solari, and J. Tschopp. 1995. Granzyme A is an interleukin 1β-converting enzyme. J. Exp. Med. 181:1917.
15. Knudsen, P. J., C. A. Dinarello, and T. B. Strom. 1986. Purification and characterization of a unique human interleukin 1 from the tumor cell line U937. J. Immunol. 136:3311.
16. Mizutani, H., N. Schechter, G. Lazarus, R. A. Black, and T. S. Kupper. 1991. Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cells chymase. J. Exp. Med. 174:821.
17. Gershenwald, J. E., Y. Fong, T. J. I. Fahey, S. E. Calvano, R. Chizzonite, P. L. Kilian, S. F. Lowry, and L. L. Moldawer. 1990. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA 87:4966.
18. Zheng, H., D. Fletcher, W. Kozak, M. Jiang, K. Hofmann, C. A. Conn, D. Soszynski, C. Grabiec, M. E. Trumbauer, A. Shaw, M. J. Kostura, K. Stevens, H. Rosen, R. J. North, H. Y. Chen, M. J. Tocci, M. J. Kluger, and L. H. T. Van der Ploeg. 1995. Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice. Immunity 3:9.
19. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin-6 deficient mice. J. Exp. Med. 180:1243.
20. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
21. Czop, J. K. 1986. Phagocytosis of particulate activators of the alternative complement pathway: effect of fibronectin. Adv. Immunol. 38:361.
22. Goris, R. J. A., W. K. F. Boekholtz, I. P. T. van Bebber, J. K. S. Nuytinck, and P. H. M. Schillings. 1986. Multiple-organ failure and sepsis without bacteria: an experimental model. Arch. Surg. 121:897.
23. Perretti, M., E. Solito, and L. Parente. 1992. Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions 35:71.
24. Miller, B. E., P. A. Krasney, D. M. Gauvin, K. B. Holbrook, D. J. Koonz, R. V. Abruzzese, R. E. Miller, K. A. Pagani, R. E. Dolle, M. A. Ator, and S. C. Gilman. 1995. Inhibition of mature IL-1β production in murine macrophages and a murine model of inflammation by WIN 6794, an inhibitor of IL-1β converting enzyme. J. Immunol. 154:1331.
25. Sipe, J. D., W. A. Gonnerman, L. D. Loose, G. Knapschaefer, W. J. Xie, and C. Franzblau. 1989. Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J. Immunol. Methods 125:125.
26. Herzyk, D. J., A. E. Berger, J. N. Allen, and M. D. Wewers. 1992. Sandwich ELISA formats designed to detect 17 kDa IL-1β significantly underestimate 35 kDa IL-1β. J. Immunol. Methods 148:243.
27. Spector, W. G., and D. A. Willoughby. 1959. The demonstration of the role of mediators in turpentine pleurisy in rats by experimental suppression of the inflammatory changes. J. Pathol. Bacteriol. 77:1.
28. Mariano, M., and V. C. Araujo. 1971. Relation between diaphragmatic mast-cell activity and exudate formation in acute experimental pleurisy. J. Pathol. 104:275.
29. Williams, D. M., and N. W. Johnson. 1978. Early colonisation of a local inflammatory lesion and its relationship to changes in systemic leucocyte availability: a study of turpentine-induced lesions in the rat. J. Pathol. 125:139.
30. Kernoff, L., and J. Colman. 1982. Neutropenia fails to prevent the acute phase stimulation of fibrinogen synthesis. Thromb. Res. 28:47.
31. Shornick, L. P., P. De Togni, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, T. A. Ferguson, and D. D. Chaplin. 1996. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J. Exp. Med. 183:1427.
32. Fantuzzi, G., H. Zheng, R. Faggioni, F. Benigni, P. Ghezzi, J. D. Sipe, A. R. Shaw, and C. A. Dinarello. 1996. Effect of endotoxin in interleukin-1β-deficient mice. J. Immunol. 157:291.
33. Kumar, S. 1995. ICE-like proteases in apoptosis. Trends Biochem. Sci. 20:198.
34. Wang, S.-D., K.-J. Huang, Y.-S. Lin, and H.-Y. Lei. 1994. Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152:5014.
35. Enari, M., R. V. Talanian, W. W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723.
36. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78.
37. Los, M., M. Van de Craen, L. C. Penning, H. Schenk, M. Westendorp, P. A. Bauerle, W. Droge, P. H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81.
38. Cozzolino, F., A. Rubartelli, D. Aldinucci, R. Sitia, M. Torcia, A. Shaw, and R. Di Guglielmo. 1989. Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 86:2369.
39. Estrov, Z., R. A. Black, R. Kurzrock, M. Wetzler, P. R. Sleath, E. H. Estey, D. Harris, Q. Van, and M. Talpaz. 1994. IL-1β converting enzyme (ICE) inhibitor suppresses AML blast proliferation. Blood 84:380 (Abstr.).
40. Stosic-Grujicic, S., N. Basara, P. Milenkovic, and C. A. Dinarello. 1995. Modulation of acute myeloblastic leukemia (AML) cell proliferation and blast colony formation by antisense oligomer of IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-1ra). J. Chemother. 7:67.
41. Ku, G., T. Faust, L. L. Lauffer, D. J. Livingtson, and M. W. Harding. 1996. Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 8:377.
42. Geiger, T., H. Towbin, A. Cosenti-Vargas, O. Zingel, J. Arnold, C. Rordorf, M. Glatt, and K. Vosbeck. 1993. Neutralization of interleukin-1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associate acute-phase response. Clin. Exp. Rheumatol. 11:515.
43. van der Berg, W. B., L. A. Joosten, M. Helsen, and F. A. van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95:237.